| Literature DB >> 29099767 |
Faiza Saleem1,2, Abdul Rauf Shakoori3.
Abstract
The Cry (crystal) proteins from Bacillus thuringiensis are known to have toxicity against a variety of insects and have been exploited to control insect pests through transgenic plants and biopesticides. B. thuringiensis SBS BT-1 carrying the cry2 genes was isolated from soil samples in Pakistan. The 2-kb full length cry2Ac gene was cloned, sequenced, and submitted to the EMBL DNA database (Accession No. AM292031). For expression analysis, Escherichia coli DH5α was transformed with the fragment sub-cloned in pET22b expression vector using NdeI and HindIII restriction sites, and later confirmed by restriction endonuclease analysis. To assess the toxicity of Cry2Ac7 protein against lepidopteran and dipteran insects, BL21 (codon plus) strain of E. coli was further transformed with the recombinant plasmid. The 65-kDa protein was expressed in the form of inclusion bodies up to 180 OD units per liter of the medium. Inclusions were washed with a buffer containing 1.5% Triton-X 100 and >90% pure Cry2Ac7 was obtained. The inclusion bodies were dissolved in 50 mM K₂CO₃ (pH 11.5), dialyzed, and freeze-dried. This freeze-dried protein as well as inclusion bodies were used in bioassays against larvae of Helicoverpa armigera and Musca domestica. The freeze-dried protein was toxic to H. armigera larvae with an LC50 value of 131 ng/mL. However, Cry2Ac7 produced in E. coli did not show any mortality to M. domestica larvae. This is the first report of Cry2Ac protein toxic to H. armigera.Entities:
Keywords: Bacillus thuringiensis (Bt); Helicoverpa armigera; Musca domestica; bioassays; cloning; cry2Ac7 gene; protein expression
Mesh:
Substances:
Year: 2017 PMID: 29099767 PMCID: PMC5705973 DOI: 10.3390/toxins9110358
Source DB: PubMed Journal: Toxins (Basel) ISSN: 2072-6651 Impact factor: 4.546
Figure 1Optimization of Cry2Ac7 expression in BL21 (codon plus) (a) Molecular weight marker (lane 1), induction with 2.0 mM, 1.5 mM, 1.0 mM, 0.5 mM IPTG at 37 °C (lanes 2–5), uninduced sample (lane 6), induction with 2.0 mM, 1.5 mM, 1.0 mM, 0.5 mM at 25 °C (lanes 7–10), induced and uninduced pET22b (lanes 11 and 12). (b) Molecular weight marker (lane 1), induction with 0.5 mM IPTG at 16 °C for 2, 4, 6, and 8 h (lanes 3, 5, 7, and 11), induction with 0.5 mM IPTG at 25 °C for 0, 2, 4, 6, and 8 h (lanes 2, 4, 6, 8, and 10).
Figure 2Purification of inclusion bodies of Cry2Ac7 expressed in BL21 (codon plus) induced with 0.5 mM IPTG at 25 °C for 4 h: Molecular weight marker (lane 1), total cell protein (lane 2), pellet 1 (lane 3), supernatant 1 (lane 4), pellet 1 (lane 5), supernatant 2 (lane 6), pellet 3 (lane 7), supernatant 3 (lane 8), pellet 4 (lane 9), supernatant 4 (lane 10), pellet 5 (lane 11), supernatant 5 (lane 12).
Figure 3Bioassays of Helicoverpa armigera with Cry2Ac7 protein, in the form of freeze-dried powder and inclusion bodies. Mortality was determined using Probit analysis [24].
Figure 4Growth difference in first instar larvae of H. armigera after feeding for four days on normal synthetic diet (a) and on diet with Cry2Ac7 protein (b).
CLUSTALW (2.1) multiple sequence alignment of Cry2Ac1, Cry2Ac7, and Cry2Ac5 proteins.
| y2Ac5 | MNNVLNSGRNTTCHAHNVVAHDPFSFEHKSLNTIEKEWKEWRRTDHSLYVAPIVGTVGSF |
| Cry2Ac7 | MNTVLNNGRNTTCHAHNVVAHDPFSFEHKSLNTIEKEWKEWKRTDHSLYVAPIVGTVGSF |
| Cry2Ac1 | MNTVLNNGRNTTCHAHNVVAHDPFSFEHKSLNTIEKEWKEWKRTDHSLYVAPIVGTVGSF |
| **.***.**********************************:****************** | |
| Cry2Ac5 | LLKKVGSLVGKRILSELQNLIFPSGSIDLMQEILRATEQFINQRLNADTLGRVNAELAGL |
| Cry2Ac7 | LLKKVGSLVGKRILSELQNLIFPGGSIDLMQEILRATEQFINQRLNADTLGRVNAELAGL |
| Cry2Ac1 | LLKKVGSLVGKRILSELQNLIFPSGSIDLMQEILRATEQFINQRLNADTLGRVNAELAGL |
| ***********************.************************************ | |
| Cry2Ac5 | QANVAEFNRQVDNFLNLNQNPVPLAIIDSVNTLQQLFLSRLPQFQIQGYQLLLLPLFAQA |
| Cry2Ac7 | QANVAEFNRQVDNFLNPNQNPVPLAIIDSVNTLQQLFLSRLPQFQIQGYQLLLLPLFAQA |
| Cry2Ac1 | QANVAEFNRQVDNFLNPNQNPVPLAIIDSVNTLQQLFLSRLPQFQIQGYQLLLLPLFAQA |
| **************** ******************************************* | |
| Cry2Ac5 | ANLHLSFIRDVILNADEWGISAATVRTYRDHLRNFTRDYSNYCINTYQTAFRGLNTRLHD |
| Cry2Ac7 | ANLHLSFIRDVILNADEWGISAATVRTYRDHLRNFTRDYSNYCINTYQTAFRGLNTRLHD |
| Cry2Ac1 | ANFNLSFIRGVILNADEWGISAATVRTYRDHLRKFHRDYSNYCINPYQTAFRGLNHRLPD |
| **::*****.***********************:* *********.********* ** * | |
| Cry2Ac5 | MLEFRTYMFLNVFEYVSIWSLFKYQSLLVSSGANLYASGSGPTQSFTAQNWPFLYSLFQV |
| Cry2Ac7 | MLEFRTYMFLNVFEYVSIWSLFKYQSLLVSSGANLYASGSGPTQSFTAQNWPFLYSLFQV |
| Cry2Ac1 | MLEFRTYMFLNVFEYVSIWSLFKYQSLLVSSGANLYASGSGPTQSFTAQNWPFLYSLFQV |
| ************************************************************ | |
| Cry2Ac5 | NSNYVLNGLSGARTTITFPNIGGLPGSTTTQTLHFARINYRGGVSSSRIGQANLNQNFNI |
| Cry2Ac7 | NSNYVLNGLSGARTTITFPNIGGLPGSTTTQTLHFARINYRGGVSSSRIGQANLNQNFNI |
| Cry2Ac1 | NSNYVLNGLSGARTTITFPNIGGLP-VYHNSTLHFARINYRGGVSSSRIGQANLNQNFNI |
| ************************* ..***************************** | |
| Cry2Ac5 | STLFNPLQTPFIRSWLDSGTDREGVATSTNWQSGAFETTLLRFSIFSARGNSNFFPDYFI |
| Cry2Ac7 | STLFNPLQTPFIRSWLDSGTDREGVATSTNWQSGAFETTLLRFSIFSARGNSNFFPDYFI |
| Cry2Ac1 | STLFNPLQTPFIRSWLDSGTDREGVATSTNWQSGAFETTLLRFSIFSARGNSNFFPDYFI |
| ************************************************************ | |
| Cry2Ac5 | RNISGVVGTISNADLARPLHFNEIRDIGTTAVASLVTVHNRKNNIYDTHENGTMIHLAPN |
| Cry2Ac7 | RNISGVVGTISNADLARPLHFNEIRDIGTTAVASLVTVHNRKNNIYDTHENGTMIHLAPN |
| Cry2Ac1 | RNISGVVGTISNADLARPLHFNEIRDIGTTAVASLVTVHNRKNNIYDTHENGTMIHLAPN |
| ************************************************************ | |
| Cry2Ac5 | DYTGFTVSPIHATQVNNQIRTFISEKYGNQGDSLRFELSNTTARHTLRGNGNSYNLYLRV |
| Cry2Ac7 | DYTGFTVSPIHATQVNNQIRTFISEKYGNQGDSLRFELSNTTARYTLRGNGNSYNLYLRV |
| Cry2Ac1 | DYTGFTVSPIHATQVNNQIRTFISEKYGNQGDSLRFELSNPTARYTLRGNGNSYNLYLRV |
| ****************************************.***:*************** | |
| Cry2Ac5 | SSIGSSTIRVTINGRVYTANVNTTTNNDGVLDNGARFSDINIGNVVASANTNVPLDIQVT |
| Cry2Ac7 | SSIGSSTIRVTINGRVYTANVNTTTNNDGVLDNGARFSDINIGNVVASANTNVPLDIQVT |
| Cry2Ac1 | SSIGSSTIRVTINGRVYTANVNTTTNNDGVLDNGARFSDINIGNVVASANTNVPLDIQVT |
| ************************************************************ | |
| Cry2Ac5 | FNGNPQFELMNIMFVPTNIPPLY |
| Cry2Ac7 | FNGNPQFELMNIMFVPTNLPPLY |
| Cry2Ac1 | FNGNPQFELMNIMFVPTNLPPLY |
| ******************:**** |
Variation in the amino acid sequences of Cry2Ac1, Cry2Ac5, and Cry2Ac7 proteins.
| Amino Acid | Cry2Ac1 | Cry2Ac5 | Cry2Ac7 |
|---|---|---|---|
| 3 | Asn | Thr | |
| 7 | Ser | Asn | |
| 42 | Arg | Lys | |
| 84 | Ser | Ser | Gly |
| 137 | Leu | Pro | |
| 183 | Phe | Leu | |
| 184 | Asn | His | |
| 190 | Gly | Asp | |
| 214 | Lys | Asn | |
| 216 | His | Thr | |
| 226 | Pro | Thr | |
| 236 | His | Thr | |
| 239 | Pro | His | |
| 326 | Insertion | Gly | |
| 327 | Val | Ser | |
| 328 | Tyr | Thr | |
| 329 | His | Thr | |
| 330 | Asn | Thr | |
| 331 | Ser | Gln | |
| 521 | Pro | Thr | |
| 525 | His | Tyr | |
| 619 | Ile | Leu |
Figure 5Multiple sequence alignment of Cry2Ac7 protein with Cry2Ac8, Cry2Ac9, and Cry2Ac12 reported from Pakistani isolates. Cry2Ac11 (HD29) is the positive control.